Patent ID: 11857610
Assignee: CSL BEHRING AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 3:
4. The method of claim 1, wherein the subject is administered (a) at least one immunosuppressive agent comprising methylprednisone, methylprednisolone, or another steroid agent; (b) 1-2 mg/kg methylprednisone or methylprednisolone per day following an HCT procedure; (c) at least one immunosuppressive agent comprising tacrolimus, cyclosporine, another calcineurin inhibitor, and/or methotrexate; or (d) mycophenolate mofetil (MMF), an anti-TNF antibody, antilymphocyte globulin (ATG), and/or mesenchymal stem cells.